2l3i
From Proteopedia
(Difference between revisions)
| (6 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
| + | |||
==Oxki4a, spider derived antimicrobial peptide== | ==Oxki4a, spider derived antimicrobial peptide== | ||
| - | <StructureSection load='2l3i' size='340' side='right' caption='[[2l3i | + | <StructureSection load='2l3i' size='340' side='right'caption='[[2l3i]]' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[2l3i]] is a 1 chain structure. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2L3I OCA]. <br> | + | <table><tr><td colspan='2'>[[2l3i]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Oxyopes_takobius Oxyopes takobius]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2L3I OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2L3I FirstGlance]. <br> |
| - | </td></tr><tr><td class="sblockLbl"><b> | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR, 20 models</td></tr> |
| - | <tr><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2l3i FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2l3i OCA], [https://pdbe.org/2l3i PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2l3i RCSB], [https://www.ebi.ac.uk/pdbsum/2l3i PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2l3i ProSAT]</span></td></tr> |
| - | <table> | + | </table> |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 12: | Line 13: | ||
Novel lynx spider toxin shares common molecular architecture with defense peptides from frog skin.,Dubovskii PV, Vassilevski AA, Samsonova OV, Egorova NS, Kozlov SA, Feofanov AV, Arseniev AS, Grishin EV FEBS J. 2011 Sep 20. doi: 10.1111/j.1742-4658.2011.08361.x. PMID:21933345<ref>PMID:21933345</ref> | Novel lynx spider toxin shares common molecular architecture with defense peptides from frog skin.,Dubovskii PV, Vassilevski AA, Samsonova OV, Egorova NS, Kozlov SA, Feofanov AV, Arseniev AS, Grishin EV FEBS J. 2011 Sep 20. doi: 10.1111/j.1742-4658.2011.08361.x. PMID:21933345<ref>PMID:21933345</ref> | ||
| - | From | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> |
</div> | </div> | ||
| + | <div class="pdbe-citations 2l3i" style="background-color:#fffaf0;"></div> | ||
== References == | == References == | ||
<references/> | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: | + | [[Category: Large Structures]] |
| - | [[Category: | + | [[Category: Oxyopes takobius]] |
| - | [[Category: | + | [[Category: Arseniev AS]] |
| - | [[Category: | + | [[Category: Dubovskii PV]] |
| - | [[Category: | + | [[Category: Egorova NS]] |
| - | [[Category: | + | [[Category: Feofanov AV]] |
| - | [[Category: | + | [[Category: Grishin EV]] |
| - | [[Category: | + | [[Category: Kozlov SA]] |
| - | [[Category: | + | [[Category: Samsonova OV]] |
| - | [[Category: | + | [[Category: Vassilevski AA]] |
Current revision
Oxki4a, spider derived antimicrobial peptide
| |||||||||||
